MicroRNA-134 plasma levels before and after treatment for bipolar mania

Journal of Psychiatric Research

Volumn 45, Issue 1, 2011, Pages 92-95

  Rong, Han ^a   Liu, Tie Bang ^a   Yang, Kong Jun ^a   Yang, Hai Chen ^a   Wu, Dong Hui ^a   Liao, Chun Pin ^a   Hong, Fei ^a   Yang, He Zen ^a   Wan, Feng ^a   Ye, Xiao Ying ^a   Xu, Dan ^a   Zhang, Xuan ^a   Chao, Chang An ^a   Shen, Qi Jie ^a  

^a SHENZHEN KANGNING HOSPITAL   (China)

Author keywords

Bipolar mania; MicroRNA; MiR 134

Indexed keywords

CLOZAPINE; LITHIUM; MICRORNA; MICRORNA 134; OLANZAPINE; OXCARBAZEPINE; QUETIAPINE; RISPERIDONE; UNCLASSIFIED DRUG; VALPROIC ACID;

ADULT; ARTICLE; BECK RAFAELSEN MANIC SCALE; BIPOLAR I DISORDER; BIPOLAR MANIA; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BIPOLAR DISORDER; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PLASMA; PSYCHIATRIC STATUS RATING SCALES; YOUNG ADULT;

EID: 78650965343     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.04.028     Document Type: Article

References (16)

1. Bech P., Bolwig T.G., Kramp P., Rafaelsen O.J. The Bech-Rafaelsen mania scale and the Hamilton depression scale. Acta Psychiatrica Scandinavica 1979, 59(4):420-423.
2. Chen X., Ba Y., Ma L., Cai X. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 2008, 18(10):997-1006.
3. Cheng H.Y., Papp J.W., Varlamova O., Dziema H., Russell B., Curfman J.P., et al. MicroRNA modulation of circadian-clock period and entrainment. Neuron 2007, 54(5):813-829.
4. Duman R.S., Malberg J., Nakagawa S., D'Sa C. Neuronal plasticity and survival in mood disorders. Biological Psychiatry 2000, 48(8):732-739.
5. Frey B.N., Andreazza A.C., Ceresér K.M., Martins M.R., Valvassori S.S., Réus G.Z., et al. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Science 2006, 79(3):281-286.
6. Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., Yerushalmi N., et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008, 3(9):e3148.
7. Jornada L.K., Moretti M., Valvassori S.S., Ferreira C.L., Padilha P.T., Arent C.O., et al. Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain. Journal of Psychiatric Research 2009 Nov 30.
8. Kapsimali M., Kloosterman W.P., de Bruijn E., Rosa F., Plasterk R.H., Wilson S.W. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biology 2007, 8(8):R173.
9. Manji H.K., Moore G.J., Rajkowska G., Chen G. Neuroplasticity and cellular resilience in mood disorders. Molecular Psychiatry 2000, 5(6):578-593.
10. Miska E.A., Alvarez-Saavedra E., Townsend M., Yoshii A., Sestan N., Rakic P., et al. Microarray analysis of micro-RNA expression in the developing mammalian brain. Genome Biology 2004, 5(9):R68.
11. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences USA 2008, 105(30):10513-10518.
12. Schloesser R.J., Huang J., Klein P.S., Manji H.K. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 2008, 33(1):110-133.
13. Schratt G.M., Tuebing F., Nigh E.A., Kane C.G., Sabatini M.E., Kiebler M., et al. A brain-specific microRNA regulates dendritic spine development. Nature 2006, 439(7074):283-289.
14. Strakowski S.M., Delbello M.P., Adler C.M. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Molecular Psychiatry 2005, 10(1):105-116.
15. Yatham L., Kennedy S., Schaffer A., Parikh S., Beaulieu S., O'Donovan C. Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder. Bipolar Disorders 2009, 11(3):225-255.
16. Zhou R., Yuan P., Wang Y., Hunsberger J.G., Elkahloun A., Wei Y., et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 2009, 34(6):1395-1405.